A Study to Assess the Efficacy and Safety of ABTL0812

NCT03366480 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

103

Enrollment

INDUSTRY

Sponsor class

Conditions

Endometrial Cancer
Squamous Non-Small Cell Lung Cancer

Interventions

DRUG: ABTL0812 in combination with paclitaxel and carboplatin

Sponsor

Ability Pharmaceuticals SL

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]